University of Queensland - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
45
About the Report
About the Report
Summary
University Of Queensland (UQ) is a research institute. The university manages personal, career, welfare and learning issues. It conducts research in the areas of physical sciences, biological sciences, technology, biomedical and clinical health sciences, engineering, chemical sciences and environmental sciences, among others. UQ provides educational courses in the areas of arts, architecture and information technology, business, economics and law, social and behavioural sciences. The university conducts research services through its research institutes. It also offers support to research higher degree students through a broad range of scholarships and research travel awards. UQ is headquartered in Brisbane, Queensland, Australia.
University of Queensland-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
University of Queensland, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Queensland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Queensland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Queensland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Queensland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Queensland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
University of Queensland, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Botanix Pharma Enters into Research Agreement with University of Queensland 10
Cyxone Enters into Agreement with University of Queensland 11
Agilent Technologies Enters Into Research Agreement With University of Queensland 12
LEO Pharma And University of Queensland Enter Into Research Agreement For Skin Cancer 13
Ascend Biopharma Enters into Agreement with University of Queensland 14
Johnson & Johnson Enters Into Co-Development Agreement With University of Queensland 15
Licensing Agreements 16
AngioStem Enters into Licensing Agreement with Queensland University 16
University of Queensland-Key Competitors 17
University of Queensland-Key Employees 18
University of Queensland-Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Government and Public Interest 21
Aug 30, 2018: New pathway in body's immune response uncovered 21
Aug 29, 2018: Potential medical breakthroughs receive national funding 22
Jul 30, 2018: Largest genetic study of type 2 diabetes offers hope of better treatment 23
Jul 25, 2018: Dutch Viagra trial on pregnant women stopped after 11 babies die 24
Jun 28, 2018: New treatment to reverse drug resistance in some cancers 25
Jan 24, 2018: USD 69 million boost for fight against rare cancers and rare diseases 26
Jan 05, 2018: Supercharged antibiotics could turn tide against superbugs 29
Nov 22, 2017: Researchers show stress suppresses response to cancer treatments 30
Nov 21, 2017: Cure Brain Cancer Foundation: 2017 Grant Recipients Announced 31
Nov 13, 2017: Research uncovers potential new approach for treating asthma 33
Oct 13, 2017: A new tactic in the fight against drug-resistant infections 34
Sep 06, 2017: Scientists link 153 new genetic variants to osteoporosis in largest ever study 35
Sep 01, 2017: Decoding cells a step forward in reproductive technology 36
Aug 01, 2017: Targeted treatment gives new hope on breast cancer 37
Jul 31, 2017: Study opens new drug therapy targets in a range of diseases 38
Product News 39
Apr 10, 2018: Technology holds personalised cancer vaccine breakthrough 39
Feb 20, 2018: NUST MISIS Scientists Create Hybrid Nanomaterials in Fight Against Cancer and Bacteria 40
Other Significant Developments 41
Aug 01, 2018: Stem cell research to tackle blindness and congenital heart disease in kids 41
Nov 09, 2017: Australia joins world-first Human Cell Atlas effort 43
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45
List of Figure
List of Figures
University of Queensland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Queensland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Queensland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Queensland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Queensland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Queensland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Queensland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Queensland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
University of Queensland, Pharmaceuticals & Healthcare, Key Facts, 2017 2
University of Queensland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Queensland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Queensland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Queensland, Deals By Therapy Area, 2012 to YTD 2018 8
University of Queensland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Botanix Pharma Enters into Research Agreement with University of Queensland 10
Cyxone Enters into Agreement with University of Queensland 11
Agilent Technologies Enters Into Research Agreement With University of Queensland 12
LEO Pharma And University of Queensland Enter Into Research Agreement For Skin Cancer 13
Ascend Biopharma Enters into Agreement with University of Queensland 14
Johnson & Johnson Enters Into Co-Development Agreement With University of Queensland 15
AngioStem Enters into Licensing Agreement with Queensland University 16
University of Queensland, Key Competitors 17
University of Queensland, Key Employees 18
University of Queensland, Subsidiaries 19
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.